Literature DB >> 11900322

Host-defense mechanism of the ocular surfaces.

R A Sack1, I Nunes, A Beaton, C Morris.   

Abstract

The defense of the ocular surfaces presents an unique challenge in that not only must integrity be maintained against microbial, inflammatory and physical assault, but it must be done while minimizing the risk of loss of corneal transparency. This puts severe limitations on the degree to which scarring or neovascularization can occur in the cornea secondary to any infectious, inflammatory, immunological or wound healing process. Moreover, this defense system must be equally effective under two extremes of conditions: those found in the open eye and the closed eye environments. It is our contention that these constraints have resulted in the evolution of a highly complex fail-safe defense system that utilizes distinctly different strategies in open and closed eye conditions. The extraordinary effectiveness of this system is evidenced by the fact that despite continued exposure to a microbe rich environment, the external ocular surfaces maintain a very low microbial titer and are highly resistant to breaching by all but a few pathogens. It is the intent of this review to provide a working model of this defense system as it operates under both open and closed eye conditions, to provide evidence in support of this model as well as highlight some of the many areas of uncertainty.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11900322     DOI: 10.1023/a:1017943826684

Source DB:  PubMed          Journal:  Biosci Rep        ISSN: 0144-8463            Impact factor:   3.840


  22 in total

Review 1.  The role of eye-associated lymphoid tissue in corneal immune protection.

Authors:  Erich Knop; Nadja Knop
Journal:  J Anat       Date:  2005-03       Impact factor: 2.610

Review 2.  Toll-like receptors and corneal innate immunity.

Authors:  Ashok Kumar; Fu-Shin X Yu
Journal:  Curr Mol Med       Date:  2006-05       Impact factor: 2.222

3.  Defensins and other antimicrobial peptides at the ocular surface.

Authors:  Alison M McDermott
Journal:  Ocul Surf       Date:  2004-10       Impact factor: 5.033

Review 4.  Antimicrobial compounds in tears.

Authors:  Alison M McDermott
Journal:  Exp Eye Res       Date:  2013-07-20       Impact factor: 3.467

5.  In vitro studies on the antimicrobial peptide human beta-defensin 9 (HBD9): signalling pathways and pathogen-related response (an American Ophthalmological Society thesis).

Authors:  Harminder S Dua; Ahmad Muneer Otri; Andrew Hopkinson; Imran Mohammed
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

6.  Syndecan-1 promotes Staphylococcus aureus corneal infection by counteracting neutrophil-mediated host defense.

Authors:  Atsuko Hayashida; Shiro Amano; Pyong Woo Park
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

7.  Effect of preservative-free artificial tears on the antimicrobial activity of human beta-defensin-2 and cathelicidin LL-37 in vitro.

Authors:  Ling C Huang; Daniele Jean; Alison M McDermott
Journal:  Eye Contact Lens       Date:  2005-01       Impact factor: 2.018

Review 8.  [Dry eye disease as a complex dysregulation of the functional anatomy of the ocular surface. New concepts for understanding dry eye disease].

Authors:  E Knop; N Knop; H Brewitt
Journal:  Ophthalmologe       Date:  2003-11       Impact factor: 1.059

9.  Proteomic analysis of human meibomian gland secretions.

Authors:  P S Tsai; J E Evans; K M Green; R M Sullivan; D A Schaumberg; S M Richards; M R Dana; D A Sullivan
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

10.  Ocular surface expression and in vitro activity of antimicrobial peptides.

Authors:  Ling C Huang; Daniele Jean; Rita J Proske; Rose Y Reins; Alison M McDermott
Journal:  Curr Eye Res       Date:  2007 Jul-Aug       Impact factor: 2.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.